Concepedia

Yvette van Hensbergen

YV

Statistics

Publications

15

Citations

732

H-Index

13

Active since

1998

Affiliations

Sanquin(Current)

Leiden University Medical Center

Vrije Universiteit Amsterdam

Amsterdam UMC Location Vrije Universiteit Amsterdam

Jon J van Rood Centre for Clinical Transfusion Research

Yvette van Hensbergen is an author at Sanquin specializing in medicine, hematology, and platelet physiology.

Publications per year

1998–2015

15

Publications

15

p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300.

Rajani Ravi, Bijoyesh Mookerjee, Yvette van Hensbergen et al. · PubMed · 1998 · 156 citations

, , +14

Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.

Baukelien van Triest, Herbert M. Pinedo, Yvette van Hensbergen et al. · PubMed · 1999 · 145 citations

, , +11

Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.

Yvette van Hensbergen, Henk J. Broxterman, Roeland Hanemaaijer et al. · PubMed · 2002 · 81 citations

, , +9

A doxorubicin–CNGRC-peptide conjugate with prodrug properties

Yvette van Hensbergen, Henk J. Broxterman, Yvonne W. Elderkamp et al. · Biochemical Pharmacology · 2002 · 78 citations

, , +14

Reduced Growth, Increased Vascular Area, and Reduced Response to Cisplatin in CD13-Overexpressing Human Ovarian Cancer Xenografts

Yvette van Hensbergen, Henk J. Broxterman, Sareena Rana et al. · Clinical Cancer Research · 2004 · 49 citations · Full text

, , +11

1–5 of 15